Anthracycline Dose Intensification in Acute Myeloid Leukemia
Hugo F. Fernández(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Martin S. Tallman(Memorial Sloan Kettering Cancer Center), Hillard M. Lazarus(University Hospitals of Cleveland), Janis Racevskis(Montefiore Medical Center), John M. Bennett(University of Rochester Medical Center), Jacob M. Rowe(Technion – Israel Institute of Technology), Rhett P. Ketterling(Mayo Clinic in Arizona), Elisabeth Paietta(Montefiore Medical Center), Mark R. Litzow(Mayo Clinic in Arizona), Zhuoxin Sun(Dana-Farber Cancer Institute), Xiaopan Yao(Dana-Farber Cancer Institute), Gordon W. Dewald(Mayo Clinic), Selina M. Luger(University of Pennsylvania)
Cited by 907
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k